cephradine has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Duan, Q; Fan, X; Guo, J; Ke, C; Shi, F; Wu, D; Xiao, J; Zeng, X; Zhang, G; Zhou, J; Zhu, F | 1 |
| Lipman, RP; Silverman, W | 1 |
1 trial(s) available for cephradine and Dermatitis
| Article | Year |
|---|---|
An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children.
Topics: Administration, Oral; Bacterial Infections; Cephalexin; Cephalosporins; Cephradine; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis; Double-Blind Method; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Infant; Infant, Newborn; Male; Pneumococcal Infections; Proteus Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Urinary Tract Infections | 1977 |
1 other study(ies) available for cephradine and Dermatitis
| Article | Year |
|---|---|
Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase.
Topics: Animals; Cell Line; Cephradine; Dermatitis; Humans; Keratinocytes; MAP Kinase Kinase 4; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Skin; Ultraviolet Rays | 2016 |